Leqembi & Health Equity

<p>Listen to Health Affairs Ryann Tanap and Vabren Watts in the first of many "Health Equity Corner" episodes on <em>This Week </em>discuss the latest from the health equity department and unpack what Leqembi, the newly approved Alzheimer's disease drug, could mean in the health equity space.</p><p><strong>Related Links:</strong></p><ul> <li> <a href="https://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-alzheimers-disease-treatment">FDA Grants Accelerated Approval for Alzheimer's Disease Treatment</a> (FDA)</li> <li><a href="https://www.cms.gov/newsroom/press-releases/cms-statement-fda-accelerated-approval-lecanemab#:~:text=CMS%20is%20examining%20available%20information,development%2C%20on%20the%20same%20day">CMS Statement on FDA Accelerated Approval of Lecanemab</a></li> <li> <a href="https://www.nbcnews.com/health/health-news/new-alzheimers-drug-will-cost-26500-year-will-able-get-rcna64883">A New Alzheimer's Drug Will Cost $26,500 A Year. Who Will Be Able To Get It?</a> (<em>NBC News</em>)</li> <li><a href="https://www.healthaffairs.org/racism-and-health?utm_medium=podcast&amp;utm_source=This+week&amp;utm_content=racism+health+issue"><em>Health Affairs </em>Racism and Health Theme Issue</a></li> <li><a href="https://www.healthaffairs.org/health-affairs-fellowships?utm_medium=podcast&amp;utm_source=This+week&amp;utm_content=fellowships"><em>Health Affairs </em>Fellowships</a></li> </ul><p>C<em>urrently, more than 70 percent of our content is freely available — and we’d like to keep it that way. </em><a href="https://www.healthaffairs.org/subscribe/individual?utm_medium=podcast&amp;utm_source=this+week&amp;utm_campaign=individual+subscriptions"><em>With your support,</em></a> <em>we can continue to keep our digital publication Forefront</em> <em>and podcasts free for everyone.</em></p>